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Abstract
The serotonin 5-HT2C receptor (5-HT2CR) is localized to the limbic-corticostriatal circuit, which plays an integral role in
mediating attention, motivation, cognition, and reward processes. The 5-HT2CR is linked to modulation of mesoaccumbens
dopamine neurotransmission via an activation of c-aminobutyric acid (GABA) neurons in the ventral tegmental area (VTA).
However, we recently demonstrated the expression of the 5-HT2CR within dopamine VTA neurons suggesting the possibility
of a direct influence of the 5-HT2CR upon mesoaccumbens dopamine output. Here, we employed double-label fluorescence
immunochemistry with the synthetic enzymes for dopamine (tyrosine hydroxylase; TH) and GABA (glutamic acid
decarboxylase isoform 67; GAD-67) and retrograde tract tracing with FluoroGold (FG) to uncover whether dopamine and
GABA VTA neurons that possess 5-HT2CR innervate the nucleus accumbens (NAc). The highest numbers of FG-labeled cells
were detected in the middle versus rostral and caudal levels of the VTA, and included a subset of TH- and GAD-67
immunoreactive cells, of which .50% also contained 5-HT2CR immunoreactivity. Thus, we demonstrate for the first time
that the 5-HT2CR colocalizes in DA and GABA VTA neurons which project to the NAc, describe in detail the distribution of
NAc-projecting GABA VTA neurons, and identify the colocalization of TH and GAD-67 in the same NAc-projecting VTA
neurons. These data suggest that the 5-HT2CR may exert direct influence upon both dopamine and GABA VTA output to the
NAc. Further, the indication that a proportion of NAc-projecting VTA neurons synthesize and potentially release both
dopamine and GABA adds intriguing complexity to the framework of the VTA and its postulated neuroanatomical roles.
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Introduction
The ventral tegmental area (VTA; A10) is the site of origin of
dopamineneuronsthatsendefferentprojectionstoavarietyofareas
throughout the brain [1–3], a large proportion of which project to
the nucleus accumbens (NAc) [3]. This dopamine mesoaccumbens
projection plays an integral role in mediating attention, motivation,
cognition, and reward processes[4], and has also been implicated in
the actions of drugs of abuse such as cocaine [5,6].
The serotonin 5-HT2C receptor (5-HT2CR), one of thirteen G-
protein coupled serotonin receptor subtypes [7], has been described
to exert an overall inhibitory influence over the function of the
dopamine mesoaccumbens pathway (for reviews, see [5,8,9]). Given
that stimulation of the 5-HT2CR is expected to evoke neuronal
depolarization [10], the 5-HT2CR-induced inhibition of basal firing
VTA dopamine neurons and release of dopamine in the NAc [11–
13] is historically thought to be mediated via depolarization of
inhibitory c-aminobutyric acid (GABA) neurons that synapse onto
dopamine cell bodies in the VTA [11–13]. Interestingly, the 5-
HT2CR has also been identified within neurons labeled with the
dopamine synthetic enzyme tyrosine hydroxylase (TH) [14]. Our
previous study demonstrated 5-HT2CR colocalization within dopa-
mine neurons [14] in VTA subnuclei that serve as the origin of the
densest efferent projections from the VTA to the NAc [3]. Thus, 5-
HT2CR modulation of the output of the mesoaccumbens pathway is
multifaceted at both the level of the dopamine and GABA neurons of
the VTA. Further, there is a high potential for the 5-HT2CRt o
influence VTA output to the NAc and, likewise, the numerous
physiological and psychological processes mediated by this pathway.
The goal of the present study was to examine the distribution of
5-HT2CR in dopamine and GABA VTA neurons that project to
the NAc shell employing double-label fluorescence immunohisto-
chemistry and retrograde tracing with the compound FluoroGold
(FG). Double-label fluorescence immunohistochemistry for TH+5-
HT2CR and glutamic acid decarboxylase isoform 67 (GAD-67)+5-
HT2CR was performed on VTA sections from brains of male
Sprague-Dawley rats that received a unilateral injection of FG into
the NAc shell [15]. An assessment of cells labeled for FG+TH+5-
HT2CR indicates the localization of 5-HT2CR on dopamine
neurons that project to the NAc, while colocalization of
FG+GAD-67+5-HT2CR reflects the presence of 5-HT2CRo n
GABA projection neurons to the NAc. Additionally, given the
recent evidence of coexpression of TH- and GAD-IR in the VTA
[16], we also examined the presence of cells labeled for
FG+TH+GAD-67 to identify mesoaccumbens neurons that have
the potential to synthesize both neurotransmitters.
Methods
Ethics Statement
All experiments conformed to the NIH Guide for the Care and
Use of Laboratory Animals and were approved by the University
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protocol 88-03-039.
Animals and Retrograde Tracing
Naı ¨ve male Sprague-Dawley rats (n=6; virus antibody-free;
Harlan, Houston,TX) aged 8–10 weeks and weighing 250–300 g
were used in these studies. All rats were maintained in the colony
room for a minimum of seven days after arrival, where food and
water was available ad libitum. Rats were deeply anesthetized using
an intramuscular injection of 43 mg/kg of ketamine, 8.6 mg/kg of
xylazine and 1.5 mg/kg of acepromazine in 0.9% saline. With the
upper incisor bar of a stereotaxic instrument positioned at
23.3 mm below the interaural line and using the intersection of
bregma and longitudinal sutures as the origin, FluoroGold (FG;
Fluorochrome, Englewood, CO) was unilaterally injected into the
NAc shell at 1.4 mm anterior to bregma, 0.75 mm lateral to the
midline, and 8.0 mm ventral to the skull surface [17]. A 1–2% FG
solution (dissolved in 0.9% saline) was injected through a 5 mL
Hamilton syringe fitted with a 26 gauge, blunt-tip (style 3) needle
(part #7768-02; Hamilton Company, Reno, NV) mounted onto a
stereotaxic frame. The injection was driven by a Micro4
Controller (World Precision Instruments, Sarasota, FL) at a rate
of 10 nL/min over 10 min for a total volume of 100 nL. The
syringe was left in place for an additional 10 min to allow for full
diffusion of the solution out of the syringe. The needle was then
reversed slowly to minimize leakage of FG into the infusion track.
Following infusion, rats received a single injection of sodium
ampicillin after surgery and recovered for one week, during which
the rats were handled and weighed daily.
Seven days following FG infusion, rats were deeply anesthetized
with pentobarbital (100 mg/kg, IP) then perfused transcardially
with phosphate buffered saline (PBS) followed by ,500 ml of 3%
paraformaldehyde in PBS. Brains were then removed, post-fixed
for 2 h in 3% paraformaldehyde in PBS, then cryoprotected in
30% sucrose for 2 days at 4uC. Using crushed dry ice, the brains
were rapidly frozen and stored at –80uC until sectioning. Coronal
sections containing the NAc (30 mm; bregma +0.70 mm through
+2.0 mm) and VTA (20 mm; bregma 24.8 mm through
26.5 mm) were taken from all brains using a cryostat (Leica
CM 1850 at 20uC; Leica Microsystems, Bannockburn, IL)
according to the atlas of Paxinos and Watson [17]. Free floating
sections were processed as described below.
Antibodies
The primary antibodies employed in the present studies include,
the goat polyclonal anti-5-HT2CR antibody [SR-2C (N-19); Santa
Cruz Biotechnology, Santa Cruz, CA], the mouse monoclonal
anti-TH antibody (#22941; Immunostar, Hudson, WI), and the
rabbit polyclonal anti-GAD 67 antibody (GAD-67; H101; Santa
Cruz Biotechnology). Additional details are summarized in
Table 1. Fluorescent-conjugated secondary antibodies (1:2000)
obtained from Molecular Probes were utilized to visualize primary
antibody staining: Alexa Fluor 488 donkey anti-goat, Alexa Fluor
555 donkey anti-rabbit, Alexa Fluor 555 donkey anti-mouse. The
Alexa Fluor 488 antibody has an excitation/emission maxima of
491/515 and appears green, while the Alexa Fluor 555 antibodies
have an excitation/emission maxima of 573/596 and appear red.
Double-label immunohistochemistry experiments for 5-HT2CR
plus TH and 5-HT2CR plus GAD-67 were performed, as well as
immunohistochemistry in the presence or absence of each
antibody alone, on the FG-injected rat brains to determine the
distribution of 5-HT2CR on dopamine and GABA cells that
project to the NAc, respectively. To examine the possibility of co-
labeling of TH and GAD-67 in the same cells, we also conducted
double-label immunohistochemistry on FG-labeled cells in the
VTA sections for TH plus GAD-67 using Alexa Fluor 488 goat
anti-mouse, and Alexa Fluor 555 goat anti-rabbit secondary
antibodies, respectively, in one brain.
Antibody Characterization
SR-2C (N-19). This anti-5-HT2CR antibody (sc-15081, Santa
Cruz Biotechnology) recognizes amino acids 27–45 of the 5-
HT2CR, as determined by MALDI-TOF/TOF mass spectrometry
(Applied Biosystems 4800 TOF/TOF) of the blocking peptide (sc-
15081-P, Santa Cruz) and confirmed by a representative from
Santa Cruz (personal communication). The robust and
reproducible pattern of immunostaining previously demonstrated
with the N-19 antibody in mouse and rat brain [14,18,19] was
consistent with that documented using a laboratory-generated 5-
HT2CR antibody designed against a different epitope [20].
Further, immunostaining for the N-19 antibody was eliminated
in transgenic mice lacking the 5-HT2CR gene relative to wild type
mice [18]. In addition, this anti-5-HT2CR antibody did not stain
parental Chinese hamster Ovary (CHO) K1 cells (which do not
express the 5-HT2CR mRNA) [21,22] or CHO cells that stably
express the closely-related 5-HT2AR [18]. Western blot analyses of
cortical rat brain tissue revealed multiple immunoreactive bands
within the predicted molecular weight range of the 5-HT2CR
which were eliminated via peptide neutralization (sc-15081-P,
Santa Cruz Biotechnology) [19,22] and absent in peripheral
organs that do not express the 5-HT2CR transcript (e.g., kidney,
lung) [22]. The anti-5-HT2CR-immunoreactive bands were also
present in immunoblots of CHO cells that stably express the 5-
HT2CR, but were not observed in immunoblots of parental CHO
K1 cells which lack the 5-HT2CR [22]. In the CHO cells stably
expressing the 5-HT2CR, the blocking peptide (sc-15081-P, Santa
Cruz Biotechnology) effectively blocked the immunoreactive signal
produced by the N19 antibody (sc-15081, Santa Cruz); this was
demonstrated using both standard fluorescence immuno-
cytochemistry as well as a fixed-cell quantitative plate
immunoassay [23] (unpublished observations).
TH. This anti-TH antibody (#22941, Immunostar), raised
against TH purified from rat PC12 cells, produces patterns of
immunoreactive staining in the VTA [14,24] similar to that
reported using other anti-TH antibodies [1,25,26]. Anti-TH
immunostaining was eliminated by preabsorption of the
antibody with a high concentration of TH [27], as well as
following toxin-induced lesions of catecholamine neurons [28].
The antibody was characterized in Western blot analyses by
Immunostar (Hudson, WI), and was shown to recognize the
expected single band of 60 kD in cell extracts of HEK293 cells
transiently transfected with cDNA of human TH isoform without
cross-reactivity with dihydropterdine reductase, dopamine- b-
hydroxylase, phenylethanolamine-N-methyltransferase, pheny-
lalanine hydroxylase, or tryptophan hydroxylase or related
enzymes.
GAD-67 (H101). This anti-GAD 67 antibody (sc-5602, Santa
Cruz Biotechnology), raised against amino acids 1–101 of the
enzyme, detects similar numbers of cells as detected using an anti-
GABA antibody in immunohistochemical analyses [29].
Validation studies conducted by Santa Cruz Biotechnology
revealed that the anti-GAD-67 antibody detected the decrease in
GAD-67 protein expression induced by GAD-67 siRNA
transfection in HeLa cells (C. Maraviglia, Santa Cruz
Biotechnology, personal communication). In addition, using this
antibody, a decrease in GAD-67-IR staining in the VTA was
observed in parallel with a decrease in GAD-67 mRNA expression
following neurotoxic lesion of VTA GABA neurons [24].
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number of GAD-67-expressing cells was detected using this
antibody in either Western blot or immunohistochemical
analysis, an observation that paralleled the increase in GABA-
positive cells induced by lipopolysaccharide [29].
Immunohistochemistry
Using established techniques [14,18,19], free floating rat brain
sections were washed using an orbital shaker in PBS (2610 min),
then incubated in 20 mM sodium acetate (1615 min, RT), and
washed again (3610 min) with PBS. The sections were then
incubated in a blocking serum (1.5% normal donkey or goat serum
in PBS) for one hour (RT). The blocking serum was aspirated, and
the sections were then incubated with primary antibodies (see
Table 1) diluted in 1.5% normal donkey or goat serum for 44 h
on an orbital shaker at 4uC. The sections were then washed with
PBS (666 min) on an orbital shaker and incubated with the
secondary antibodies diluted in 1.5% normal donkey or goat
serum for 1 h at room temperature (protected from light). The
sections were washed with PBS (3610 min) and mounted using a
0.1% Drefts solution onto slides previously coated with gelatin
chrom alum. The slides were then coverslipped using Vectashield
fluorescent mounting medium (Vector Laboratories), and stored
protected from light at 4uC until viewing.
Image Analysis
Digital images were captured from brain sections using an
Olympus BX51 fluorescent microscope equipped with a Hama-
matsu digital camera (Hamamatsu, Bridgewater, NJ) interfaced to
a personal computer and were adjusted using Simple PCI software
(version 5.1, Compix Inc., Imaging Systems, Cranberry Township,
PA). A 10x, 20x or 40x objective was used to capture all
photomicrographs for final magnification of 200x, 400x or 800x,
respectively. Green fluorescence emitted by the Alexa Fluor 488
antibodies was visualized using a yellow GFP filter set (#41017;
Chroma Technology Corporation, Rockingham, VT), while the
red fluorescence emitted by the Alexa Fluor 555 antibodies was
visualized using a narrow band green excitation filter set (U-
MNG2, Olympus). In addition, FG staining was visualized using a
wideband ultraviolet excitation filter set (U-MWU2, Olympus).
Three images of the same viewing area were captured for each
section, one for each filter set, and then resultant images were
merged. Antibody-specific IR was defined as IR that was visible in
tissue sections labeled with the appropriate primary-secondary
antibody combination, but was not detectable in control sections
containing either the primary or secondary antibody alone. The
brightness and contrast of each image was adjusted to eliminate
background staining; the settings differed for each antibody
utilized and were based upon the level of background staining in
the control sections (no primary antibody) that were processed
simultaneously for each brain analyzed.
Rostro-caudal patterns of FG labeling and 5-HT2CR-, TH-, and
GAD-67-IR were analyzed at rostral (bregma 25.00 to
Table 1. Primary antibodies employed in the experiments.
Antibody SR-2C (N-19) Tyrosine Hydroxylase GAD-67 (H101)
Immunogen Human 5-HT2CR N-terminus (27-45) Tyrosine hydroxylase purified from rat PC12
cells
Human GAD-67 N-terminus (1-101)
Manufacturer Santa Cruz Biotechnology (Santa Cruz,
CA)
Immunostar (Hudson, WI) Santa Cruz Biotechnology (Santa Cruz,
CA)
Catalog/lot # sc-15081/G102 22941/136932 sc-5602/B211
Species Goat polyclonal Mouse monoclonal Rabbit polyclonal
Dilution 1:100 1:3000 1:150
doi:10.1371/journal.pone.0020508.t001
Figure 1. FluoroGold staining at injection site in the NAc.
Schematic diagrams depicting coronal sections of the NAc shell and
surrounding brain areas at bregma +2.16, +1.80 and +1.56 mm [17]
overlaid on top of a representative composite photomicrographs
depicting the FG injection sites (100 nL; 1–2% FG) for the three animals
with injections correctly placed in the NAc shell.
doi:10.1371/journal.pone.0020508.g001
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(bregma 26.00 to –6.40 mm) levels of the VTA [17]. Three to
four FG+TH+5-HT2CR-labeled sections and adjacent (when
possible) FG+GAD-67+5-HT2CR-labeled sections per each ros-
tro-caudal level were examined from each rat identified as having
an accurately placed unilateral injection of FG into the NAc shell
(n=3 of 6). For each section, a composite photomicrograph
comprised of 20–30 individual images captured using the 20x
objective was assembled to visualize the entire VTA. Labeled cells
were identified in each section and manually counted using the
‘‘Count’’ feature of the Adobe Photoshop CS4 Extended software
(Adobe Systems Incoprorated, San Jose, CA). First, with only the
blue channel visible, all FG-labeled cells were counted and marked
with a blue square. Next, using blue and red channels, each
FG+TH- or FG+GAD-67-labeled cell (depending on the staining
for the particular section) was counted and marked with a red
square. Then, using the blue and green channels and with the
TH/GAD-67 count group invisible, all FG+5-HT2CR-labeled
cells were counted and marked with a green square. Finally, using
the blue channel only and with all three count groups visible, each
cell that contained blue, red and green squares were marked and
counted as being labeled for FG+TH+5-HT2CRo rF G +GAD-
67+5-HT2CR (depending on the staining combinations for the
particular section); each cell that contained blue and red squares
only were marked and counted as being labeled for FG+TH or
FG+GAD-67; and each cell that contained blue and green squares
were marked and counted as being labeled for FG+5-HT2CR. The
total number of cells labeled for FG, FG+TH or FG+GAD-67,
FG+5-HT2CR, and FG+TH+5-HT2CRo rF G +GAD-67+5-
HT2CR were recorded for each section. [14,30].
The total number FG-labeled cells for each section was
averaged (6 SEM) for rostral, mid and caudal levels. Likewise,
the total number of TH-IR cells (sum of FG+TH plus FG+TH+5-
HT2CR), GAD-67-IR cells (sum of FG+GAD-67 plus FG+GAD-
67+5-HT2CR) and 5-HT2CR-IR cells (sum of FG+5-HT2CR plus
FG+TH+5-HT2CR, or FG+5-HT2CR plus FG+GAD-67+5-
HT2CR) were calculated for each appropriately-labeled section
and then averaged (6 SEM) for rostral, mid and caudal levels.
Subsequently, the percentage of FG+TH or FG+GAD-67-labeled
cells was determined by dividing the number of total FG+TH- or
FG+GAD-67-labeled cells, respectively, by the total number of
FG-labeled cells in that section. The resultant values were
averaged (mean 6 SEM) for rostral, middle, and caudal levels.
In addition, the percentage of FG+TH- or FG+GAD-67-labeled
cells that also contained 5-HT2CR-IR was determined for each
section by dividing the number of FG+TH+5-HT2CR- or
FG+GAD-67+5-HT2CR-labeled cells by the total FG+TH- or
FG+GAD-67-labeled cells, respectively. A one-way analysis of
variance (ANOVA) was used to determine significant differences
in: (1) the number of FG-, FG+TH-, FG+GAD-67-, or FG+5-
HT2CR-labeled cells across the three rostro-caudal levels of the
VTA: (2) the percentage of total FG+TH-, FG+GAD-67-,
FG+TH+5-HT2CR-, or FG+GAD-67+5-HT2CR-labeled cells
detected in the rostral, middle and caudal levels of the VTA
[31]. Significant effects were followed with post hoc analyses using
the Student Newman Keuls procedure [32].
To verify the observation of colocalization of FG+TH+5-HT2CR
and FG+TH+GAD, brain sections from one additional animal with
a FG injection correctly placed in the NAc shell were processed, as
described above, and viewed in the BSL2-Advanced Optical
Microscopy Core of the UTMB Galveston National Laboratory
using an Olympus Fluoview 1000 UV laser scanning confocal
microscope mounted on an upright BX61 microscope (Olympus
America Inc., Center Valley, PA). Images were captured using a
60x 1.2NA water immersion lens (Olympus). Sets of images were
captured with the Fluoview Workstation software (Olympus) using
three different fluorescent filter sets to detect the individual
fluorophores and the resultant images were overlaid. A series of
consecutive image sets were captured at approximately 0.5 mm
intervals through the depth of the 20 mm section of the VTA.
Results
Retrograde Labeling with FG
Of the six animals that received FG injections for semi-
quantitative analyses of immunolocalization, three animals had
unilateral injections that were correctly placed in the NAc shell
(Fig. 1). The locations of the three NAc shell injections and the
extent of lateral diffusion of FG from the injection site to adjacent
brain areas are portrayed in Fig. 1. The FG immunofluorescence
was primarily confined to the NAc shell with some diffusion into
the NAc core, ventral pallidum and islands of calleja/olfactory
tubercle (Fig. 1). Of the remaining three animals, two of the
injections were slightly lateral, with diffusion of FG limited to the
Figure 2. FluoroGold-labeled cells in the VTA following NAc FG
infusion. Schematic diagrams depicting coronal sections of the rostral
[bregma 25.16 mm; A], middle [bregma 25.64 mm; B], and caudal
[bregma 26.12 mm; C,] levels of the VTA [17] and surrounding brain
areas overlaid on top of representative composite photomicrographs
from Rat #3 (see Fig. 1) displaying FG (blue) labeling in the VTA one
week following infusion of FG into the NAc shell. [D, E, F] Higher power
magnification of yellow boxed regions in A, B, and C, respectively. Scale
bars =30 mm.
doi:10.1371/journal.pone.0020508.g002
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septum/diagonal band (data not shown). Only the three brains
with injections correctly placed in the NAc shell were processed for
a semi-quantitative analysis of double-label fluorescence immuno-
histochemistry. One additional animal that received a unilateral
FG injection correctly placed in the NAc shell was utilized for
confocal microscopy analysis (data not shown).
Intense labeling for FG was detected in cell bodies and processes
in the VTA of rats injected with FG into the NAc (see Figs. 2;
3A,B; 4A). FG-labeled cells were visible throughout the rostro-
caudal extent of the VTA (Fig. 2). The vast majority of FG-
labeled cells were confined to the side of the brain ipsilateral to the
injection site (see Figs. 2, 3A). However, a small number of FG-
labeled cells were visible in the contralateral VTA, as well as in the
Figure 3. Colocalization of TH and 5-HT2CR immuonoreactivity with FG-labeled cells in the VTA. [A] Representative composite
photomicrograph of the middle level of the VTA displaying the overlay of FG (blue), TH-IR (red) and 5-HT2CR-IR (green). Inset displays the schematic
diagram of the middle VTA (shaded area) and surrounding brain areas [interpeduncular nucleus (IP); medial laminiscus (ml); mammillary peduncle
(mp); substantia nigra pars compacta, dorsal tier (SNCD); substantial nigra reticulata (SNR)] at bregma 25.64 mm [17]. High magnification images of
the boxed region in panel A depict FG labeling [blue; B], TH-IR [red, C], and 5-HT2CR-IR [green, D], as well as the overlay of images in B, C and D to
demonstrate colocalization [E]. Filled arrows (L) indicate cells triple-labeled for FG+TH+5-HT2CR, while open arrows (I) indicate a cell double-labeled
for FG+TH; Scale bars =20 mm. Note: Portions of IP nucleus present in the composite photomicrograph in panel A were removed from the image
prior to incorporation into the figure.
doi:10.1371/journal.pone.0020508.g003
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combined) provides a schematic illustration of the distribution of
all FG-labeled cells detected in a single rostral (Fig. 5A), middle
(Fig. 5B,), and caudal (Fig. 5C) section of the VTA.
The total numberof FG-labeled cells countedinthe VTAofeach
brain (11 sections/brain; n=3 brains) ranged from 1781–2934. A
significant main effect of rostro-caudal level on the distribution of
FG cells was observed (F2,63=34.71; p,0.0001; Table 2).
Significant differences in the average (6SEM) number of FG-
labeled cells detected per section were observed between all rostro-
caudal levels. The highest number of FG-labeled cells were detected
in the middle sections (140.9667.84), followed by the rostral level
(97.0068.30),andthelowestnumberofFG-labeled cellsdetected in
the caudal VTA (47.2866.73) (p,0.001; Table 2). In the rostral
VTA, the FG-labeled cells were most abundant in the ventromedial
portions of the VTA subnuclei, with some cells dispersed lateral to
the fasciculus retroflexus (fr; see Fig. 5A). In the middle level, FG-
labeled cells concentrated in the ventral portion of the VTA
adjacent to the interpeduncular nucleus (IP; see Fig. 5B). In the
caudal VTA, FG-labeled cells were concentrated medially, with a
few labeled cells scattered laterally (see Fig. 5C).
Distribution of FG+TH-labeled cells
Immunofluorescence studies for TH in VTA sections following
unilateral injection of FG into the NAc shell revealed that a subset
of FG-labeled cells in the VTA contained TH-IR (Figs. 3, 4, 5).
Figure 3 displays representative photomicrographs demonstrat-
ing colocalization of FG+TH in the middle VTA using light
microscopy (see L and I in Fig. 3B,C). The presence of TH-IR
within FG-labeled cells was confirmed using confocal microscopy
(compare Fig. 4A with 4B). A main effect of rostro-caudal level
was observed for the distribution of FG+TH cells in the VTA
(F2,30=28.13; p,0.0001; Table 2). In accordance with that
observed for total FG-labeled cells, significant differences in the
average (6SEM) number of FG+TH-labeled cells detected per
section were observed amongst all the rostro-caudal levels, with
middle (103.4269.40) . rostral (61.3365.25) . caudal
(29.6764.60) (p,0.01; Table 2). There was no main effect of
rostro-caudal level for the percentage of total FG cells containing
TH-IR (,68-76%; F2,30=0.89; p,0.42; Table 2), suggesting that
a similar proportion of FG cells were positive for TH-IR across all
rostro-caudal levels.
Figure 5 illustrates the distribution of all FG-labeled cells
detected in one rostral (Fig. 5A), middle (Fig. 5B) and caudal
section (Fig. 5C) of the VTA of a rat injected with FG into the
NAc shell and stained for TH and 5-HT2CR IR; the total
population of FG-labeled cells that also contained TH-IR include
the blue circles, representing cells labeled for FG+TH only, and
the red stars, representing cells labeled for FG+TH+5-HT2CR (see
‘‘Distribution of 5-HT2CRi nF G +TH-labeled cells,’’ below). In
general, FG+TH-labeled cells were interspersed among all FG-
labeled cells detected in the VTA. Of note, virtually all of the FG-
labeled cells located in the medial portion of the rostral VTA
immediately dorsal to the interpeduncular fossa (IPF) were co-
labeled with TH-IR (Fig. 5A). In the middle level, almost all of the
FG-labeled cells located most ventrally along the interpeduncular
Figure 4. Colocalization of FG, TH and 5-HT2CR in the VTA. Images display FG- [blue, A], TH- [red, B] and 5-HT2CR-labeling [green, C] in series of
five sequential photomicrographs (from left to right) captured using a confocal microscope in the VTA of a rat injected with FG in the NAc shell.
Photomicrographs represent images captured at a distance of 1.0 mm apart through the thickness of the brain section. [D] Overlay of images in A–C
shows colocalization of TH and 5-HT2CR in a FG-labeled cell in the VTA. Scale bar =10 mm.
doi:10.1371/journal.pone.0020508.g004
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caudal VTA, all FG+TH-labeled cells were concentrated along the
midline (Fig. 5C).
Distribution of FG+GAD-67-labeled cells
A subset of FG cells throughout the VTA contained GAD-67-
IR (Figs. 6, 7, 8). Figure 6 displays representative photomicro-
Figure 5. Distribution of FG- TH- and 5-HT2CR-labeled cells in the VTA. Schematic representation of the location of cells labeled for FG alone
(black squares), FG+TH (blue circles), FG+5-HT2CR (green triangles) and FG+TH+5-HT2CR-labeled cells (red stars) in the [A] rostral (,bregma
25.12 mm), [B] middle (,bregma 25.67 mm), and [C] caudal (,bregma 26.30 mm) levels of the VTA [17]. Insets display schematic diagrams
depicting the location of VTA (shaded) relative to surrounding brain areas [interpeduncular nucleus (IP); interpeduncular fossa (IPF); medial laminiscus
(ml); mammillary peduncle (mp); mammillothalamic tract (MT) substantia nigra pars compacta, dorsal tier (SNCD); substantia nigra pars compacta,
medial tier (SNCM); substantial nigra reticulata (SNR)] [17]. Data represent the number and distribution of cells counted in one rostral, middle or
caudal section from an animal injected with FG in the NAc shell.
doi:10.1371/journal.pone.0020508.g005
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Fig. 6B,C) in the middle VTA using light microscopy. The
presence of GAD-67-IR within FG-labeled cells was confirmed
using confocal microscopy (compare Fig. 7A with 7B). A main
effect of rostro-caudal level was observed for the distribution of
FG+GAD-67 cells in the VTA (F2,30=17.41; p,0.0001; Table 2).
As observed for total FG-labeled cells, significant differences in the
average (6SEM) number of FG+GAD-67-labeled cells detected
per section were observed amongst all the rostro-caudal levels,
across middle (70.0865.87) . rostral (47.8365.98) . caudal
(22.1165.19) localization planes (p,0.01; Table 2). There was no
main effect of rostro-caudal level on the percentage of total FG-
labeled cells containing GAD-67-IR (,47-49%; F2,30=0.23;
p=0.79; Table 2), suggesting that a similar proportion of FG
cells were positive for GAD-67-IR across all rostro-caudal levels.
Figure 8 illustrates the distribution of all FG-labeled cells
detected in one rostral (Fig. 8A), middle (Fig. 8B), and caudal
section (Fig. 8C) of the VTA of a rat injected with FG into the
NAc shell and stained for GAD-67 and 5-HT2CR IR; the total
population of FG-labeled cells that also contained GAD-67-IR
include the blue circles, representing cells labeled for FG+GAD-67
only, and the red stars, representing cells labeled for FG+GAD-
67+5-HT2CR (see ‘‘Distribution of 5-HT2CRi nF G +GAD-67-
labeled cells,’’ below). In general, FG+GAD-67-labeled cells were
interspersed among all FG-labeled cells detected in the rostral,
middle and caudal VTA (Fig 8A-C). Notably, in the rostral VTA,
the majority of FG-labeled cells along the the dorsal end of the
midline [dorsal to the fasciculus retroflexus (fr)] contained GAD-
67-IR (blue circles and red stars, Fig. 8A).
Distribution of FG+5-HT2CR-labeled cells
As described previously (Bubar et al., 2005; Bubar and
Cunningham, 2007), 5-HT2CR-IR was prominently distributed in
the membrane and cytoplasm of both TH-IR and GAD-67-IR
perikarya, with potential localization in neuronal processes. 5-
HT2CR-IR was found to be localized to a subset of FG-labeled cells
in the VTA (Table 2, Figs. 3, 4, 5, 6, 7, 8). Figures 3 and 6
display representative photomicrographs demonstrating colocaliza-
tion of FG+5-HT2CR (see L in Figs. 3B,D; 6B,D) in the middle
VTA using light microscopy. The presence of 5-HT2CR-IR within
FG-labeled cells was confirmed using confocal microscopy (com-
pareFig.4Awith4Cand Fig.7Awith7C).Amaineffectofrostro-
caudal level was observed for the distribution of FG+5-HT2CR-
labeled cells in the VTA (F2,63=45.40; p,0.0001; Table 2). In
accordance with all FG-labeled cells, significant differences in the
average (6SEM) number of FG+5-HT2CR-labeled cells detected
per section were observed amongst all rostro-caudal levels of the
VTA, with middle (70.8863.80) . rostral (48.3863.37) . caudal
VTA (21.9463.47) (p,0.001; Table 2).
Figures 5 and 8 illustrate the distribution of FG-labeled cells
that contain 5-HT2CR-IR detected in one rostral (Fig. 5A, 8A),
middle (Fig. 5B, 8B), and caudal section (Fig. 5C, 8C) of the
VTA of a rat injected with FG into the NAc shell followed by
immunohistochemical detection of TH- and 5-HT2CR-IR, or
GAD-67 and 5-HT2CR-IR, respectively. The total population of
FG-labeled cells that contained 5-HT2CR-IR are represented by
the green triangles (FG+5-HT2CR-labeled cells, Figs 5 and 8)
and red stars combined (FG+TH+5-HT2CR, Fig. 5;F G +GAD-
67+5-HT2CR, Fig. 8). The 5-HT2CR-IR cells were interspersed
among all FG-labeled cells throughout the rostral, middle and
caudal levels of the VTA (Figs. 5A–C and 8A–C).
Distribution of 5-HT2CR-IR in FG+TH-labeled cells
Immunoreactivity for the 5-HT2CR was observed to be present in
the just over half of the FG+TH-labeled cells (Table 2; Figs. 3, 4,
5), ranging from ,56–58% of total FG+TH-labeled cells throughout
the VTA. Figure 3 displays representative photomicrographs
demonstrating colocalization of FG+TH+5-HT2CR( s e eL in
Fig. 3B-E) in the VTA using light microscopy. The presence of
both TH- and 5-HT2CR-IR in the same FG-labeled cell was
Table 2. Total FG-labeled cells containing immunoreactivity for TH, GAD-67, and 5-HT2CR.
Level Rostral Middle Caudal ANOVA
Bregma Location (mm)
a 25.00 to 25.40 25.50 to 25.90 26.00 to 26.40
Number per section:
FG
b 97.0068.30 140.9667.84** 47.2866.73**‘ F2,63=34.71 p, 0.0001
FG+TH
b 61.3365.25 103.4269.40** 29.6764.60*‘ F2,30=28.13 p, 0.0001
FG+GAD-67
b 47.8365.98 70.0865.87* 22.1165.19*‘ F2,30=17.41 p, 0.0001
FG+5-HT2CR
c 48.3863.37 70.8863.80** 21.9463.47**‘ F2,63=45.40 p, 0.0001
Percentages:
%FG+TH
d 68.3163.47 75.7364.42 69.4666.23 F2,30=0.89 p= 0.42
%FG+TH+5-HT2CR
e 57.1764.29 58.3463.73 55.5066.24 F2,30=0.10 p= 0.91
%FG+GAD
f 48.5961.53 49.0260.87 46.7962.05 F2,30=0.64 p= 0.53
%FG+GAD-67+5-HT2CR
g 59.6663.18 55.5762.22 52.6064.64 F2,30=1.24 p= 0.30
aBregma locations according to the brain atlas of Paxinos and Watson (1998).
bAverage (6 SEM) per section of 12 rostral and middle sections, 9 caudal sections.
cAverage (6 SEM) number of total FG+5-HT2CR-labeled cells per section in 24 rostral and middle, 18 caudal sections.
dAverage (6 SEM) of FG+TH-labeled cells/total FG cells in 12 rostral and middle, 9 caudal sections.
eAverage (6 SEM) of FG+TH+5-HT2CR-labeled cells/total FG+TH-labeled cells in 12 rostral and middle, 9 caudal sections.
fAverage (6 SEM) of FG+GAD-67-labeled cells/total FG cells in 12 rostral and middle, 9 caudal sections.
gAverage (6 SEM) of FG+GAD-67+5-HT2CR-labeled cells/total FG/+GAD-67-labeled cells in 12 rostral and mid, 9 caudal sections.
**p,0.001 vs. rostral level;
*p,0.01 vs. rostral level;
‘p,0.001 vs. middle level.
doi:10.1371/journal.pone.0020508.t002
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effectofrostro-caudallevelonthepercentageofFG+TH-labeledcells
containing 5-HT2CR-IR (F2,30 =0.10;p=0.91;Table 2),suggesting
a relatively equal distribution of 5-HT2CR-IR in FG+TH labeled
cells across rostral-caudal levels of the VTA. As illustrated in Fig. 5,
no obvious patterns of distribution were noted for FG+TH+5-
HT2CR-labeled cells, although in the rostral and middle VTA, in
particular, the vast majority (.75%) of the 5-HT2CR-IR detected
was localized to FG cells that also contained TH-IR (Fig. 5A–C).
Distribution of 5-HT2CR-IR in FG+GAD-67-labeled cells
Immunoreactivity for the 5-HT2CR was detected in ,53–60%
of FG+GAD-67-labeled cells identified throughout the VTA
(Table 2; Figs. 6, 7, 8). Figure 6 displays representative
photomicrographs demonstrating colocalization of FG+GAD-
67+5-HT2CR (see L in Fig. 6B-E) in the middle VTA using
light microscopy. The presence of both GAD-67- and 5-HT2CR-
IR in the same FG-labeled cell was confirmed using confocal
microscopy (Fig. 7). There was no main effect of rostro-caudal
Figure 6. Colocalization of GAD-67 and 5-HT2CR immuonoreactivity with FG-labeled cells in the VTA. [A] Representative composite
photomicrograph of the middle level of the VTA displaying the overlay of FG (blue), GAD-67-IR (red) and 5-HT2CR-IR (green). Inset displays the
schematic diagram of the middle VTA (shaded area) and surrounding brain areas (see Fig. 3 for abbreviations) at bregma -5.64 mm [17]. High
magnification images of the boxed region in panel A depict FG labeling [blue; B], GAD-67-IR [red, C], and 5-HT2CR-IR [green, D], as well as the overlay
of images in B, C, and D to demonstrate colocalization [E]. Filled arrows (L) indicate cells triple-labeled for FG+GAD-67+5-HT2CR cells, while the open
arrows (I) indicate a cell double-labeled for FG+5-HT2CR; as noted in the text, cells labeled for FG+GAD-67 alone were not often detected in the area
represented by the boxed region. Scale bars =20 mm. Note: Portions of IP nucleus present in the composite photomicrograph in panel A were
removed from the image prior to incorporation into the figure.
doi:10.1371/journal.pone.0020508.g006
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HT2CR-IR (F2,30=1.24; p=0.30; Table 2), suggesting a
relatively equal distribution of 5-HT2CR-IR in FG+GAD-67-
labeled cells across rostral-caudal levels of the VTA. As illustrated
in Fig. 8, 5-HT2CR-IR was in general equally distributed between
FG+GAD-67-labeled cells and those labeled with FG alone (see I
in Fig. 6B-E). Of note, virtually all of the FG+GAD-labeled cells
in the medial portion of the middle VTA just dorsal to the IP also
contained 5-HT2CR-IR (Figs. 6 and 8B).
TH and GAD colocalization in the VTA
The recent report that TH- and GAD-IR co-label in VTA cells
[16] and the observation that the sum of the percentage of
FG+TH-labeled cells (68-76%) plus FG+GAD-67-labeled cells
(47-49%) was slightly greater than 100% for all levels of the VTA
(Table 2) prompted an examination of FG-labeled cells in VTA
for immunoreactivity for both TH and GAD-67. Figure 9
displays representative photomicrographs demonstrating colocali-
zation of FG+TH+GAD-67 the middle VTA using light
microscopy. Although a thorough analysis of the distribution was
not conducted, we examined one section/level of VTA from one
of the NAc FG-injected brains for TH and GAD-67 colocalization
(Fig. 10). From these few sections, .34% of the total FG-labeled
cells appear to contain immunoreactivity for both TH and GAD
(see L, Fig. 9B-D; red stars, Fig. 10A-C), as did a large number
of non-FG labeled cells (see , Fig. 9B-D). TH+GAD-67
colocalization was present throughout the rostro-caudal extent of
the VTA. In general, there was a higher proportion of
FG+TH+GAD-67-labeled cells (see L, Fig. 9B-D; red stars,
Fig. 10A-C) than cells labeled for FG+GAD-67 alone (see ,
Fig. 9B-D; green triangles, Fig. 10A-C), while the proportion of
FG+TH+GAD-67-labeled cells versus FG+TH-labeled cells (see
I, Fig. 9B-D; blue circles, Fig. 10A-C) was more equally
distributed. Also of note, there was a relatively high concentration
of FG+TH+GAD-67-labeled cells (red stars) with few cells labeled
for FG+GAD-67 alone (green triangles) in the ventromedial
portions of the rostral and caudal VTA just dorsal to the IP (see
Figs. 9 and 10A,C), indicating that the majority of FG+GAD-
labeled cells in these areas also contained TH.
Discussion
The present study employed a combination of FG retrograde
tracing and double-label immunofluorescence techniques to
demonstrate for the first time the localization of the 5-HT2CR
in both dopamine and GABA VTA neurons that project to the
NAc, the detailed description of NAc-projecting GABA VTA
neurons, and the colocalization of dopamine and GABA
neuronal markers in the same NAc-projecting neurons in the
VTA. The FG-labeled neurons were most frequently detected in
the middle level of the VTA, and a greater proportion of the FG-
labeled neurons contained immunoreactivity for TH (68–76%)
compared to GAD-67 (47–49%). In addition, across the rostro-
caudal extent of the VTA, just over 50% of FG+TH- or
FG+GAD-labeled cells also contained immunoreactivity for the
5-HT2CR, suggesting that the 5-HT2CR has the potential to exert
Figure 7. Colocalization of FG, GAD-67 and 5-HT2CR in the VTA. Photomicrographs display FG- [blue, A], GAD-67- [red, B] and 5-HT2CR-
labeling [green, C] in series of five sequential images (from left to right) captured using a confocal microscope in the VTA of a rat injected with FG in
the NAc shell. Photomicrographs represent images captured at a distance of 1.0 mm apart through the thickness of the brain section. [D] Overlay of
images in A-C shows colocalization of GAD-67- and 5-HT2CR-IR in a FG-labeled cell in the VTA. Scale bars =10 mm.
doi:10.1371/journal.pone.0020508.g007
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NAc-projecting VTA neurons. Furthermore, the observation that
a proportion of FG-labeled (and non-FG-labeled) cells contain
immunoreactivity for both TH and GAD-67 adds additional
complexity to the framework of the VTA and its postulated
neuroanatomical roles.
The present study demonstrates that unilateral injection of FG
into the NAc shell results in prominent labeling of cells in the
ipsilateral VTA, with significantly greater numbers of FG-labeled
cells detected in the middle level of the VTA, compared to rostral
or caudal levels. Our observation that FG-labeled neurons were
generally concentrated in the ventromedial portion of the VTA
are in congruence with previous reports describing a mediolateral
and inverted dorsoventral topography of projections from the
VTA to the NAc [1,3,15,33–35], such that projections to the
dorsomedial NAc shell, to which our FG infusions were targeted,
Figure 8. Distribution of FG- GAD-67- and 5-HT2CR-labeled cells in the VTA. Schematic representation of the location of cells labeled for FG
alone (black squares), FG+GAD-67 (blue circles), FG+5-HT2CR (green triangles) and FG+GAD-67+5-HT2CR-labeled cells (red stars) in the [A] rostral
(,bregma 25.10 mm), [B] middle (,bregma 25.69 mm), and [C] caudal (,bregma 26.26 mm) levels of the VTA [17]. Insets display schematic
diagrams depicting the location of VTA (shaded) relative to surrounding brain areas (see Fig. 5 for abbreviations) [17]. Data represent the number and
distribution of cells counted in one rostral, middle or caudal section from an animal injected with FG in the NAc shell.
doi:10.1371/journal.pone.0020508.g008
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[1,33–35]. The detection of a small number of FG-labeled cells in
the dorsolateral and dorsomedial VTA is likely due to the spread
of FG into the NAc core and olfactory tubercle/pallidal areas,
respectively [1,33].
Immunofluorescent staining for the synthetic enzymes TH and
GAD-67 confirmed that the FG-labeled VTA projection neurons
to the NAc are comprised of both dopamine and GABA neurons
[3,33,36]. Differences in the distribution patterns between NAc-
projecting dopamine vs. GABA neurons were very subtle, as the
GAD-67-labeled FG neurons were generally interspersed among
the larger population of FG+TH-labeled neurons. Here, we also
report for the first time the presence of 5-HT2CR-IR in .50% of
dopamine and GABA neurons that project from the VTA to the
Figure 9. Colocalization of TH and GAD-67 immuonoreactivity with FG-labeled cells in the VTA. [A] Representative composite
photomicrograph of the middle level of the VTA displaying the overlay of FG (blue), TH-IR (green) and GAD-67-IR (red). Inset displays the schematic
diagram of the middle VTA (shaded area) and surrounding brain areas (see Fig. 3 for abbreviations] at bregma -5.64 mm. [17]. High magnification
images of the boxed region in panel A depict FG labeling [blue, B], TH-IR [green, C], and GAD-67-IR [red, D], as well as the overlay of images in B, C,
and D to demonstrate colocalization [E]. Filled arrows (L) indicate a cell triple-labeled for FG+TH+GAD-67, open arrows (I) indicate a cell double-
labeled for FG+TH, solid arrows ( ) indicate a cell double-labeled for FG+GAD-67, and the arrowheads ( ) point to a cell double-labeled for
TH+GAD-67 in the absence of FG; Scale bars =20 mm. Note: Portions of IP nucleus present in the composite photomicrograph in panel A were
removed from the image prior to incorporation into the figure.
doi:10.1371/journal.pone.0020508.g009
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colocalization of 5-HT2CR-IR with both TH-IR and GAD-IR in
the VTA [14], as well as the suggestion by Ji et al [37] that 5-
HT2CR colocalize to VTA dopamine neurons innervating the
NAc. Although our results are in contrast to a previous in situ
hybridization study in which 5-HT2CR mRNA was detected in
VTA GABA, but not dopamine, neurons [38], there are several
explanations (e.g., differential translational efficiency and protein
turnover rates) that are likely to account for the observed
dissociation between 5-HT2CR mRNA and protein expression in
dopamine VTA neurons (see [14] for brief discussion).
The dopamine and GABA neurons that express the 5-HT2CR
were interspersed throughout the rostral-caudal extent of the
VTA, again with only subtle differences in the distribution of these
Figure 10. Distribution of FG- TH- and GAD-67-labeled cells in the VTA. Schematic representation of the location of cells labeled for FG
alone (black squares), FG+TH (blue circles), FG+GAD-67 (green triangles) and FG+TH+GAD-67-labeled cells (red stars) in the [A] rostral (,bregma
25.14 mm), [B] middle (,bregma 25.67 mm), and [C] caudal (,bregma 26.30 mm) levels of the VTA [17]. Insets display schematic diagrams
depicting the location of VTA (shaded) relative to surrounding brain areas (see Fig. 5 for abbreviations) [17]. Data represent the number and
distribution of cells counted in one rostral, middle or caudal section from a animal injected with FG in the NAc shell.
doi:10.1371/journal.pone.0020508.g010
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almost all of the FG-labeled GABA neurons in the medial VTA,
just dorsal to the interpeduncular nucleus (IP), appear to contain
5-HT2CR. Though not well studied, this area, typically referred to
as the interfascicular subnucleus of the VTA, is highly innervated
by raphe 5-HT neurons [39] and sends dense projections to the
medial NAc shell [1].
The 5-HT2CR has been thought historically to exert an
inhibitory influence upon mesoaccumbens dopamine neurotrans-
mission via induction of GABA release from axonal collaterals that
synapse upon local dopamine neurons within the VTA [12,13].
The prevailing theory is that 5-HT2CR localized to VTA GABA
interneurons mediate this effect [11–13]. However, the present
discovery that the 5-HT2CR co-localizes within NAc-projecting
GABA neurons provides an additional intriguing site of action for
5-HT2CR to modulate mesoaccumbens neurotransmission. While
the existence of non-dopaminergic efferent projections from the
VTA has been repeatedly documented [2,3,33,40], the nature and
role for these remain undisclosed. While it is probable that GABA
efferent projections to the NAc form symmetric (inhibitory)
synaptic contacts with non-GABAergic dendrites [40], further
investigation into the nature of the interactions between VTA
GABA projection neurons and these other neuronal systems
within the NAc are necessary before we fully appreciate the
functional consequences of 5-HT2CR in GABA mesoaccumbens
neurons.
Our current finding demonstrating the presence of 5-HT2CR
directly on NAc-projecting mesoaccumbens dopamine neurons
does not intuitively fit into the overall concept of 5-HT2CR
inhibition of mesoaccumbens dopamine neurotransmission, as
stimulation of these 5-HT2CR would be expected stimulate the
output of dopamine VTA neurons through an intracellular cascade
that results inneuronal depolarization [10].However,theinhibitory
control exerted by the 5-HT2CR over the output of dopamine VTA
neurons was primarily surmised from research strategies that
utilized systemic administration of 5-HT2CR ligands [11,41,42] or
local application of non-selective compounds [12,43], complicating
the interpretation that selective activation of the VTA 5-HT2CRi s
responsible. Conversely, intra-VTAinfusionof a selective 5-HT2CR
agonist, antagonist, or inverse agonist had little to no effect on basal
NAc dopamine release [44,45] while bath application of a 5-
HT2CR antagonist did not alter the spontaneous activity of VTA
dopamine neurons in vitro [46]. The present results provide the
anatomical data to support these more selective neurochemical
analyses, and suggest that under basal conditions, the subpopula-
tions of 5-HT2CR within the VTA that act upon dopamine versus
GABA neurons counterbalance one another to neutralize the
influence that either population alone exerts upon the dopamine
mesoaccumbens neurotransmission.
Antagonism of 5-HT2CR locally within the VTA, however,
dose-dependently reverses the inhibition of dopamine outflow in
the NAc induced by systemic administration of a 5-HT2CR agonist
[44]. Thus, when 5-HT2CR mechanisms extrinsic to the VTA are
engaged, the inhibitory effects of local VTA 5-HT2CR upon
phasic DA mesoaccumbens neurotransmission seem to predom-
inate. The mechanisms which underlie this effect are unclear at
this time and need to be explored. The 5-HT2CR mRNA and
protein are present in moderate to high levels throughout the
limbic-corticostriatal circuit, including the NAc, prefrontal cortex,
cingulate cortex, amygdala, ventral pallidum and hippocampus
[20,47]. Thus it is probable that 5-HT2CR localized to one or
more of the other nodes within the limbic-corticostriatal circuitry
that feed to the VTA are involved. Indeed, selective blockade of 5-
HT2CR localized to the NAc, also reversed the inhibition of NAc
dopamine outflow induced by systemic 5-HT2CR agonist
administration [44]. Thus, the NAc represents an additional site
of action through which the 5-HT2CR localized within this
complex feedback circuitry may modulate mesoaccumbens DA
neurotransmission.
Yet another layer of complexity is brought to light by the present
discovery that TH and GAD-67 are co-expressed within a
subpopulation of VTA neurons that project to the NAc.
Colocalization of GABA or GAD isoforms and synthetic enzymes
for catecholamines in the same cell has been reported throughout
the brain [48,49]. Although an early study did not detect
colocalization of GABA or GAD and TH in the VTA or the
closely related substantia nigra [49], more recent studies have
provided immunohistochemical evidence for colocalization of TH
andGADorGABAinneuronsofthe VTA[16],aswell asina large
population of substantia nigra neurons [48]. Our observations are
further substantiated by studies demonstrating the colocalization of
TH protein with GAD mRNA in the substantia nigra and lateral
VTA [50], as well as the presence of TH and GAD mRNA in the
same cell as demonstrated via single-cell RT-PCR of cells from the
VTA and/or substantia nigra [51,52]. These provocative data
suggest the possibility of simultaneous production, and perhaps
release, of the two neurotransmitters from the same VTA neurons
with terminals localized in the NAc [16].
The existence of multiple sites of action in the VTA for the 5-
HT2CR suggests that these receptors play a key role in fine-tuning
the activation of mesoaccumbens neurotransmission under
stimulated conditions. Likewise, any imbalance in this complex
5-HT2CR framework could contribute to dysregulation of
mesoaccumbens transmission, possibly contributing to associated
physiological and psychological disorders, including depression,
schizophrenia and reward-related disorders such as addiction
[6,53,54]. Or, alternatively the VTA 5-HT2CR may represent a
critical avenue for reversing/regulating such dysfunction. Indeed,
5-HT2CR ligands are under development for the treatment of
depression, schizophrenia and drug abuse [5,55]. However, much
investigation is needed to elucidate the functional roles for the
multiple sites of action for 5-HT2CR in the VTA, and importantly
to identify means to selectively target these individual subpopu-
lations of receptors. The data presented here provide the
anatomical framework upon which such detailed and selective
functional studies can be designed to more fully understand the
implications of the multiple sites of action for 5-HT2CR in the
VTA, and, furthermore, highlight the need for further investiga-
tion into the functional role of mesoaccumbens GABA neurons, as
well as the potential for co-release of dopamine and GABA from
mesoaccumbens neurons.
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